Perspective Therapeutics Inc (AAJ0)

Currency in EUR
3.16
+0.08(+2.60%)
Closed·
AAJ0 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.163.16
52 wk Range
1.5612.20
Key Statistics
Bid/Ask
3.10 / 3.22
Prev. Close
3.12
Open
3.16
Day's Range
3.16-3.16
52 wk Range
1.56-12.2
Volume
-
Average Volume (3m)
2.29K
1-Year Change
-68.71%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AAJ0 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Perspective Therapeutics Inc Company Profile

Perspective Therapeutics, Inc., together with its subsidiaries, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States. The company discovers, and develop its initial drug candidate VMT-a-NET that is in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2)-expressing neuroendocrine tumors that have not previously received peptide-targeted radiopharmaceutical therapy, such as Lutathera, a beta emitting therapy; VMT01, which is in Phase 1/2a clinical trials for second-line or later treatment of patients with progressive melanocortin 1 receptor (MC1R) positive metastatic melanoma; PSV359, a targeted alpha therapy targeting fibroblast activation protein alpha; and PSV4XX, a differentiated prostate-specific membrane antigen-targeted alpha therapy. It has a clinical trial collaboration agreement with Bristol Myers Squibb to evaluate the safety and tolerability of [212Pb] VMT01 in combination with nivolumab in patients with histologically confirmed melanoma and positive MC1R imaging scans. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 2004 and is headquartered in Seattle, Washington.

Compare AAJ0 to Peers and Sector

Metrics to compare
AAJ0
Peers
Sector
Relationship
P/E Ratio
0.0x0.0x0.0x
PEG Ratio
0.000.000.00
Price/Book
0.0x0.0x0.0x
Price / LTM Sales
0.0x0.0x0.0x
Upside (Analyst Target)
0.0%0.0%0.0%
Fair Value Upside
Unlock0.0%0.0%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

AAJ0 Income Statement

People Also Watch

18.23
SRPT
+1.50%
2.56
INMB
-8.24%
2.070
VOR
0.00%
17.75
URGN
-4.52%
2.000
IPA
+8.11%

FAQ

What Stock Exchange Does Perspective Therapeutics Inc Trade On?

Perspective Therapeutics Inc is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Perspective Therapeutics Inc?

The stock symbol for Perspective Therapeutics Inc is "AAJ0."

What Is the Perspective Therapeutics Inc Market Cap?

As of today, Perspective Therapeutics Inc market cap is 234.67M.

What Is Perspective Therapeutics Inc's Earnings Per Share (TTM)?

The Perspective Therapeutics Inc EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is AAJ0 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Perspective Therapeutics Inc Stock Split?

Perspective Therapeutics Inc has split 0 times.

What is the current trading status of Perspective Therapeutics Inc (AAJ0)?

As of 09 Aug 2025, Perspective Therapeutics Inc (AAJ0) is trading at a price of 3.16, with a previous close of 3.12. The stock has fluctuated within a day range of 3.16 to 3.16, while its 52-week range spans from 1.56 to 12.20.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.